Bolt Biotherapeutics, Inc. (BOLT) Net margin 2020–2025
Bolt Biotherapeutics, Inc. (BOLT) net profit margin by fiscal year — reported net income divided by reported revenue.
-433.7%FY2025 · since FY2020: -26289.2% → -433.7%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -433.7% | +387.0 pp |
| FY2024 | -820.8% | +57.8 pp |
| FY2023 | -878.6% | +659.2 pp |
| FY2022 | -1537.8% | +6286.9 pp |
| FY2021 | -7824.7% | +18464.5 pp |
| FY2020 | -26289.2% | — |
Net margin = reported net income ÷ reported revenue for the same fiscal year. Loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice
More BOLT financial trends
BOLT RevenueBOLT Net incomeBOLT Gross profitBOLT Gross marginBOLT Operating incomeBOLT Operating marginBOLT Operating cash flowBOLT Free cash flowBOLT Capital expendituresBOLT Return on equityBOLT Stock buybacksBOLT Dividends paidBOLT Total assetsBOLT Total liabilitiesBOLT Shareholders’ equityBOLT overview →